Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatitis B | 6 | 2022 | 695 | 1.760 |
Why?
|
Hepatitis B virus | 7 | 2022 | 513 | 1.720 |
Why?
|
Mucormycosis | 4 | 2023 | 97 | 1.680 |
Why?
|
Aspergillosis | 2 | 2023 | 235 | 1.390 |
Why?
|
Virus Activation | 7 | 2022 | 319 | 1.170 |
Why?
|
Cytomegalovirus Infections | 7 | 2023 | 820 | 1.070 |
Why?
|
Agammaglobulinemia | 2 | 2023 | 167 | 1.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 13 | 2022 | 5442 | 0.910 |
Why?
|
Mycoses | 5 | 2013 | 376 | 0.890 |
Why?
|
Antiviral Agents | 10 | 2022 | 2987 | 0.860 |
Why?
|
Respiratory Tract Infections | 2 | 2023 | 961 | 0.790 |
Why?
|
Antifungal Agents | 9 | 2023 | 730 | 0.720 |
Why?
|
Triazoles | 4 | 2019 | 911 | 0.720 |
Why?
|
Opportunistic Infections | 3 | 2015 | 389 | 0.720 |
Why?
|
Hematologic Neoplasms | 6 | 2023 | 1832 | 0.700 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2012 | 602 | 0.570 |
Why?
|
Leukemia | 3 | 2010 | 1511 | 0.540 |
Why?
|
Immunocompromised Host | 9 | 2023 | 847 | 0.520 |
Why?
|
Transplantation | 2 | 2013 | 217 | 0.480 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1031 | 0.470 |
Why?
|
Hepatitis C | 2 | 2020 | 1591 | 0.430 |
Why?
|
Neutropenia | 3 | 2023 | 895 | 0.420 |
Why?
|
Antibiotic Prophylaxis | 2 | 2008 | 639 | 0.420 |
Why?
|
Cytomegalovirus | 5 | 2021 | 732 | 0.420 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6171 | 0.410 |
Why?
|
Mycology | 1 | 2011 | 14 | 0.400 |
Why?
|
Mucorales | 1 | 2011 | 33 | 0.390 |
Why?
|
Pyrazoles | 2 | 2018 | 1972 | 0.380 |
Why?
|
Pyrimidines | 2 | 2018 | 2942 | 0.340 |
Why?
|
Viruses | 1 | 2012 | 374 | 0.320 |
Why?
|
Skin Diseases, Infectious | 1 | 2008 | 74 | 0.320 |
Why?
|
Soft Tissue Infections | 1 | 2008 | 155 | 0.290 |
Why?
|
Virus Diseases | 1 | 2012 | 711 | 0.270 |
Why?
|
B-Cell Maturation Antigen | 2 | 2023 | 140 | 0.270 |
Why?
|
Clinical Laboratory Techniques | 1 | 2011 | 738 | 0.260 |
Why?
|
Pneumonia, Pneumocystis | 2 | 2018 | 249 | 0.260 |
Why?
|
Hepatitis B Surface Antigens | 3 | 2022 | 305 | 0.260 |
Why?
|
Cord Blood Stem Cell Transplantation | 3 | 2018 | 314 | 0.260 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2007 | 232 | 0.260 |
Why?
|
Bacterial Infections | 1 | 2013 | 1401 | 0.250 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2007 | 341 | 0.240 |
Why?
|
Lung Transplantation | 1 | 2012 | 1153 | 0.240 |
Why?
|
Hepatitis B Antibodies | 2 | 2022 | 159 | 0.230 |
Why?
|
Echinocandins | 1 | 2023 | 45 | 0.230 |
Why?
|
Physicians | 1 | 2021 | 4567 | 0.220 |
Why?
|
Drainage | 1 | 2008 | 1142 | 0.220 |
Why?
|
Neoplasms | 4 | 2022 | 21683 | 0.210 |
Why?
|
Polyomavirus Infections | 2 | 2014 | 197 | 0.210 |
Why?
|
Anti-Infective Agents | 2 | 2012 | 972 | 0.210 |
Why?
|
Nitriles | 2 | 2019 | 956 | 0.200 |
Why?
|
Tumor Virus Infections | 2 | 2014 | 452 | 0.200 |
Why?
|
Antibodies, Bispecific | 1 | 2023 | 164 | 0.200 |
Why?
|
Fungi | 1 | 2023 | 327 | 0.180 |
Why?
|
Antibodies, Viral | 4 | 2023 | 3176 | 0.180 |
Why?
|
Hepacivirus | 2 | 2019 | 1379 | 0.180 |
Why?
|
Humans | 53 | 2024 | 744343 | 0.180 |
Why?
|
Staphylococcal Infections | 1 | 2008 | 1400 | 0.170 |
Why?
|
DNA, Viral | 3 | 2022 | 2225 | 0.170 |
Why?
|
Transplantation Conditioning | 2 | 2018 | 1598 | 0.170 |
Why?
|
Pneumocystis carinii | 2 | 2018 | 74 | 0.170 |
Why?
|
Tacrolimus | 1 | 2022 | 743 | 0.170 |
Why?
|
Postoperative Complications | 3 | 2020 | 15295 | 0.160 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1677 | 0.160 |
Why?
|
Immunotherapy, Adoptive | 2 | 2023 | 1270 | 0.150 |
Why?
|
Adult | 25 | 2023 | 214055 | 0.150 |
Why?
|
Adenine | 3 | 2018 | 936 | 0.150 |
Why?
|
Antineoplastic Agents | 5 | 2020 | 13695 | 0.150 |
Why?
|
BK Virus | 2 | 2014 | 129 | 0.140 |
Why?
|
Latent Tuberculosis | 1 | 2019 | 225 | 0.140 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2018 | 1052 | 0.140 |
Why?
|
Multiple Myeloma | 3 | 2023 | 5181 | 0.140 |
Why?
|
Middle Aged | 25 | 2023 | 213383 | 0.140 |
Why?
|
Hepatitis B, Chronic | 1 | 2020 | 393 | 0.140 |
Why?
|
Transplantation, Homologous | 6 | 2018 | 4776 | 0.130 |
Why?
|
Chemoprevention | 1 | 2017 | 319 | 0.130 |
Why?
|
Aged, 80 and over | 8 | 2019 | 57776 | 0.130 |
Why?
|
Pyridines | 2 | 2019 | 2825 | 0.130 |
Why?
|
Retrospective Studies | 13 | 2023 | 77449 | 0.130 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2022 | 1381 | 0.130 |
Why?
|
Aged | 18 | 2023 | 163280 | 0.120 |
Why?
|
Male | 26 | 2023 | 350118 | 0.120 |
Why?
|
Rhizomucor | 1 | 2014 | 3 | 0.120 |
Why?
|
Fetal Blood | 2 | 2018 | 1318 | 0.120 |
Why?
|
Acute Disease | 3 | 2010 | 7149 | 0.120 |
Why?
|
Methotrexate | 1 | 2020 | 1727 | 0.110 |
Why?
|
Immunosuppressive Agents | 3 | 2020 | 4149 | 0.110 |
Why?
|
Piperidines | 2 | 2018 | 1602 | 0.110 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2124 | 0.110 |
Why?
|
Virology | 1 | 2012 | 77 | 0.100 |
Why?
|
Tissue Transplantation | 1 | 2012 | 130 | 0.100 |
Why?
|
Mannans | 1 | 2011 | 63 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.100 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2011 | 62 | 0.100 |
Why?
|
Amphotericin B | 1 | 2011 | 137 | 0.100 |
Why?
|
beta-Glucans | 1 | 2011 | 123 | 0.100 |
Why?
|
Female | 22 | 2023 | 380194 | 0.090 |
Why?
|
Lymphadenitis | 1 | 2011 | 98 | 0.090 |
Why?
|
HIV | 1 | 2018 | 1604 | 0.090 |
Why?
|
Clostridium Infections | 1 | 2017 | 548 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2020 | 5221 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2020 | 1139 | 0.090 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1339 | 0.090 |
Why?
|
DNA, Ribosomal | 1 | 2011 | 290 | 0.090 |
Why?
|
Young Adult | 8 | 2019 | 56430 | 0.090 |
Why?
|
DNA, Fungal | 1 | 2011 | 280 | 0.090 |
Why?
|
Vaccination | 1 | 2022 | 3278 | 0.090 |
Why?
|
Candidiasis | 1 | 2011 | 366 | 0.080 |
Why?
|
Mycobacterium tuberculosis | 1 | 2019 | 1832 | 0.080 |
Why?
|
Candida albicans | 1 | 2011 | 394 | 0.080 |
Why?
|
Cross Infection | 1 | 2017 | 1416 | 0.080 |
Why?
|
Methicillin Resistance | 1 | 2008 | 198 | 0.080 |
Why?
|
Bone Marrow Transplantation | 1 | 2015 | 2765 | 0.070 |
Why?
|
Face | 1 | 2012 | 994 | 0.070 |
Why?
|
HIV Reverse Transcriptase | 1 | 2007 | 213 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39050 | 0.070 |
Why?
|
DNA Primers | 1 | 2011 | 2892 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14722 | 0.070 |
Why?
|
Cohort Studies | 4 | 2019 | 40561 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 11524 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2019 | 63114 | 0.060 |
Why?
|
Graft Rejection | 2 | 2020 | 4397 | 0.060 |
Why?
|
Sirolimus | 1 | 2012 | 1564 | 0.060 |
Why?
|
Community-Acquired Infections | 1 | 2008 | 465 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13102 | 0.060 |
Why?
|
Incidence | 4 | 2022 | 20947 | 0.060 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1257 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5137 | 0.060 |
Why?
|
Risk Factors | 7 | 2022 | 72290 | 0.060 |
Why?
|
Graft vs Host Disease | 3 | 2014 | 2957 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2012 | 9959 | 0.060 |
Why?
|
Unnecessary Procedures | 1 | 2007 | 432 | 0.060 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1540 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2017 | 3523 | 0.060 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2007 | 567 | 0.050 |
Why?
|
Patient Selection | 2 | 2021 | 4215 | 0.050 |
Why?
|
Ritonavir | 1 | 2023 | 322 | 0.050 |
Why?
|
Time Factors | 3 | 2012 | 40075 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12354 | 0.050 |
Why?
|
Hepatitis B Core Antigens | 1 | 2020 | 92 | 0.050 |
Why?
|
Drug Resistance, Bacterial | 1 | 2008 | 1035 | 0.050 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2022 | 419 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2007 | 1782 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2020 | 12026 | 0.040 |
Why?
|
Antigens, CD19 | 1 | 2022 | 380 | 0.040 |
Why?
|
Acetates | 1 | 2021 | 311 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4560 | 0.040 |
Why?
|
Sequence Analysis, DNA | 1 | 2011 | 4803 | 0.040 |
Why?
|
Tuberculin Test | 1 | 2019 | 214 | 0.040 |
Why?
|
Stem Cell Transplantation | 2 | 2020 | 1620 | 0.040 |
Why?
|
Cell Count | 1 | 2022 | 1856 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2011 | 2400 | 0.040 |
Why?
|
Rubella | 1 | 2018 | 48 | 0.040 |
Why?
|
Herpes Zoster Vaccine | 1 | 2018 | 47 | 0.040 |
Why?
|
Mumps | 1 | 2018 | 64 | 0.040 |
Why?
|
HIV Infections | 2 | 2018 | 16718 | 0.040 |
Why?
|
Combined Modality Therapy | 1 | 2008 | 8642 | 0.030 |
Why?
|
Societies, Medical | 2 | 2020 | 3743 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 1959 | 0.030 |
Why?
|
Measles | 1 | 2018 | 168 | 0.030 |
Why?
|
Kinetics | 1 | 2024 | 6473 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1676 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2015 | 7279 | 0.030 |
Why?
|
Quinazolines | 1 | 2021 | 1356 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2959 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15165 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1420 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2020 | 1530 | 0.030 |
Why?
|
Anthracyclines | 1 | 2015 | 288 | 0.030 |
Why?
|
Myeloablative Agonists | 1 | 2014 | 218 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 592 | 0.030 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 689 | 0.030 |
Why?
|
Drug Dosage Calculations | 1 | 2012 | 114 | 0.030 |
Why?
|
Mycophenolic Acid | 1 | 2014 | 343 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2019 | 1320 | 0.020 |
Why?
|
Fluconazole | 1 | 2011 | 146 | 0.020 |
Why?
|
Prospective Studies | 3 | 2024 | 53288 | 0.020 |
Why?
|
Adolescent | 3 | 2017 | 85781 | 0.020 |
Why?
|
Galactose | 1 | 2011 | 306 | 0.020 |
Why?
|
Serum | 1 | 2011 | 214 | 0.020 |
Why?
|
Diarrhea | 1 | 2017 | 1348 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 3913 | 0.020 |
Why?
|
Catheter-Related Infections | 1 | 2012 | 252 | 0.020 |
Why?
|
HIV-1 | 1 | 2007 | 6939 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2531 | 0.020 |
Why?
|
Proteoglycans | 1 | 2011 | 835 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8663 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3528 | 0.020 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1519 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3086 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 20822 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2242 | 0.020 |
Why?
|
Drug Synergism | 1 | 2012 | 1792 | 0.020 |
Why?
|
Reassortant Viruses | 1 | 2007 | 37 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2017 | 1352 | 0.020 |
Why?
|
Didanosine | 1 | 2007 | 153 | 0.020 |
Why?
|
Dideoxynucleosides | 1 | 2007 | 122 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3479 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6538 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 1855 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5255 | 0.020 |
Why?
|
Lamivudine | 1 | 2007 | 342 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2007 | 898 | 0.020 |
Why?
|
Tissue Donors | 1 | 2015 | 2240 | 0.020 |
Why?
|
Viral Load | 1 | 2014 | 3299 | 0.020 |
Why?
|
Codon | 1 | 2007 | 611 | 0.020 |
Why?
|
Prognosis | 2 | 2018 | 29063 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2015 | 2728 | 0.020 |
Why?
|
Disease Management | 1 | 2015 | 2459 | 0.020 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 615 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4933 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12788 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4468 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3610 | 0.010 |
Why?
|
Deoxycytidine | 1 | 2007 | 826 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8340 | 0.010 |
Why?
|
Drug Resistance, Viral | 1 | 2007 | 820 | 0.010 |
Why?
|
Graft Survival | 1 | 2012 | 3737 | 0.010 |
Why?
|
Point Mutation | 1 | 2007 | 1623 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6489 | 0.010 |
Why?
|
HeLa Cells | 1 | 2007 | 3128 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10388 | 0.010 |
Why?
|
Pneumonia | 1 | 2012 | 2133 | 0.010 |
Why?
|
Skin | 1 | 2014 | 4364 | 0.010 |
Why?
|
Liver | 1 | 2015 | 7474 | 0.010 |
Why?
|
Chronic Disease | 1 | 2014 | 9146 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15540 | 0.010 |
Why?
|
Lung | 1 | 2014 | 9856 | 0.010 |
Why?
|
United States | 1 | 2015 | 69872 | 0.000 |
Why?
|
Brain | 1 | 2014 | 26385 | 0.000 |
Why?
|